Tesfaye Latera, Forzy Tom, Getnet Fentabil, Misganaw Awoke, Woldekidan Mesfin Agachew, Wolde Asrat Arja, Warkaye Samson, Gelaw Solomon Kassahun, Memirie Solomon Tessema, Berheto Tezera Moshago, Worku Asnake, Sato Ryoko, Hendrix Nathaniel, Tadesse Meseret Zelalem, Tefera Yohannes Lakew, Hailu Mesay, Verguet Stéphane
National Data Management Center for Health, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
PLOS Glob Public Health. 2024 Jul 25;4(7):e0003404. doi: 10.1371/journal.pgph.0003404. eCollection 2024.
Ethiopia has made significant progress in the last two decades in improving the availability and coverage of essential maternal and child health services including childhood immunizations. As Ethiopia keeps momentum towards achieving national immunization goals, methods must be developed to analyze routinely collected health facility data and generate localized coverage estimates. This study leverages the District Health Information Software (DHIS2) platform to estimate immunization coverage for the first dose of measles vaccine (MCV1) and the third dose of diphtheria-pertussis-tetanus-Hib-HepB vaccine (Penta3) across Ethiopian districts ("woredas"). Monthly reported numbers of administered MCV1 and Penta3 immunizations were extracted from public facilities from DHIS2 for 2017/2018-2021/2022 and corrected for quality based on completeness and consistency across time and districts. We then utilized three sources for the target population (infants) to compute administrative coverage estimates: Central Statistical Agency, DHIS2, and WorldPop. The Ethiopian Demographic and Health Surveys were used as benchmarks to which administrative estimates were adjusted at the regional level. Administrative vaccine coverage was estimated for all woredas, and, after adjustments, was bounded within 0-100%. In regions with the highest immunization coverage, MCV1 coverage would range from 83 to 100% and Penta3 coverage from 88 to 100% (Addis Ababa, 2021/2022); MCV1 from 8 to 100% and Penta3 from 4 to 100% (Tigray, 2019/2020). Nationally, the Gini index for MCV1 was 0.37, from 0.13 (Harari) to 0.37 (Somali); for Penta3, it was 0.36, from 0.16 (Harari) to 0.36 (Somali). The use of routine health information systems, such as DHIS2, combined with household surveys permits the generation of local health services coverage estimates. This enables the design of tailored health policies with the capacity to measure progress towards achieving national targets, especially in terms of inequality reductions.
在过去二十年里,埃塞俄比亚在提高包括儿童免疫接种在内的基本妇幼保健服务的可及性和覆盖范围方面取得了重大进展。随着埃塞俄比亚朝着实现国家免疫目标不断迈进,必须开发方法来分析常规收集的卫生设施数据,并生成本地化的覆盖范围估计值。本研究利用地区卫生信息软件(DHIS2)平台,估计埃塞俄比亚各行政区(“沃雷达斯”)麻疹疫苗第一剂(MCV1)和白喉-百日咳-破伤风- Hib-乙肝疫苗第三剂(Penta3)的免疫接种覆盖率。从DHIS2的公共设施中提取了2017/2018 - 2021/2022年每月报告的MCV1和Penta3免疫接种数量,并根据时间和地区的完整性和一致性对质量进行了校正。然后,我们利用三个目标人群(婴儿)来源来计算行政覆盖范围估计值:中央统计局、DHIS2和世界人口数据。埃塞俄比亚人口与健康调查被用作基准,行政估计值在区域层面进行了调整。对所有沃雷达斯的行政疫苗覆盖率进行了估计,调整后,其范围在0 - 100%之间。在免疫接种覆盖率最高的地区,MCV1覆盖率在83%至100%之间,Penta3覆盖率在88%至100%之间(亚的斯亚贝巴,2021/2022年);MCV1在8%至100%之间,Penta3在4%至100%之间(提格雷,2019/2020年)。在全国范围内,MCV1的基尼系数为0.37,从0.13(哈拉里)到0.37(索马里);Penta3的基尼系数为0.36,从0.16(哈拉里)到0.36(索马里)。使用常规卫生信息系统(如DHIS2)并结合家庭调查,可以生成当地卫生服务覆盖范围估计值。这有助于设计有针对性的卫生政策,并有能力衡量在实现国家目标方面的进展,特别是在减少不平等方面。